Momentum Biotechnologies

Momentum Biotechnologies is a drug discovery partner based in Billerica, Massachusetts. The company is a privately held entity with 12 employees. Momentum Biotechnologies specializes in providing innovative mass spectrometry (MS) solutions to biopharmaceutical clients worldwide. They offer a range of MS-based services, including affinity selection MS (ASMS), intact mass MS, chemoproteomics, and small & biomolecule analyses. These services are designed to help clients identify and characterize drug leads for various target classes, such as degraders, molecular glues, protein-protein interaction (PPI) disrupters, and RNA binders. The company's core strength lies in its expertise in mass spectrometry and its commitment to delivering high-quality data with rapid turnaround times. Momentum Biotechnologies boasts a large mass spectrometry laboratory equipped with over 30 instruments and a fully functional biosafety level 2 (BL2) laboratory. For further details about Momentum Biotechnologies and its services, please visit their website at www.momentum.bio.